Literature DB >> 10694609

Pulmonary function after modified venovenous ultrafiltration in infants: a prospective, randomized trial.

H T Keenan1, R Thiagarajan, K E Stephens, G Williams, C Ramamoorthy, F M Lupinetti.   

Abstract

OBJECTIVE: We sought to examine the effects of modified venovenous ultrafiltration after cardiopulmonary bypass on pulmonary compliance in infants.
METHODS: We prospectively enrolled 38 infants undergoing their first operation for congenital heart disease. Infants were randomized to receive 20 minutes of modified ultrafiltration after bypass or control. Static and dynamic compliance was measured after induction of anesthesia, before and immediately after filtration in the operating theater, 1 hour after return to the pediatric intensive care unit, and 24 hours after the operation. Length of time on the ventilator, inotropic requirements, and length of stay in the intensive care unit were recorded.
RESULTS: Modified ultrafiltration produced a significant immediate improvement in dynamic (pre-ultrafiltration 2.5 +/- 1.9 mL/cm H(2)O to post-ultrafiltration 2.9 +/- 2.7 mL/cm H(2)O, P =.03) and static (pre-ultrafiltration 2.1 +/- 0.9 mL/cm H(2)O to post-ultrafiltration 2.9 +/- 2.1 mL/cm H(2)O, P =.04) compliance. However, there was no significant difference in the change in dynamic (P =.3) or static (P =.7) compliance in the ultrafiltration and control groups when compared before the operation, after the operation, and at 24 hours. There was no significant difference in the time to extubation between patients and control subjects (140 +/- 91 hours vs 90 +/- 58 hours) or the length of intensive care unit stay (10.0 +/- 9.1 days vs 7.4 +/- 5.7 days).
CONCLUSIONS: Modified ultrafiltration produces an improvement in pulmonary compliance after bypass in infants. However, these improvements are not sustained past the immediate post-ultrafiltration period and do not lead to a decreased length of intubation or intensive care unit stay.

Entities:  

Mesh:

Year:  2000        PMID: 10694609     DOI: 10.1016/s0022-5223(00)70129-2

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  7 in total

Review 1.  Recent advances in neonatal cardiac surgery.

Authors:  Chawki el-Zein; Michel N Ilbawi
Journal:  World J Surg       Date:  2008-03       Impact factor: 3.352

2.  Perioperative plasma F(2)-Isoprostane levels correlate with markers of impaired ventilation in infants with single-ventricle physiology undergoing stage 2 surgical palliation on the cardiopulmonary bypass.

Authors:  Erin Albers; Brian S Donahue; Ginger Milne; Benjamin R Saville; Wenli Wang; David Bichell; BethAnn McLaughlin
Journal:  Pediatr Cardiol       Date:  2012-02-12       Impact factor: 1.655

Review 3.  Prevention of lung injury in cardiac surgery: a review.

Authors:  Robert W Young
Journal:  J Extra Corpor Technol       Date:  2014-06

Review 4.  Modified ultrafiltration during cardiopulmonary bypass and postoperative course of pediatric cardiac surgery.

Authors:  Mohsen Ziyaeifard; Azin Alizadehasl; Gholamreza Massoumi
Journal:  Res Cardiovasc Med       Date:  2014-04-01

5.  Reevaluating the Importance of Modified Ultrafiltration in Contemporary Pediatric Cardiac Surgery.

Authors:  Vladimir Milovanovic; Dejan Bisenic; Branko Mimic; Bilal Ali; Massimiliano Cantinotti; Ivan Soldatovic; Irena Vulicevic; Bruno Murzi; Slobodan Ilic
Journal:  J Clin Med       Date:  2018-12-01       Impact factor: 4.241

Review 6.  Strategies to prevent intraoperative lung injury during cardiopulmonary bypass.

Authors:  Efstratios E Apostolakis; Efstratios N Koletsis; Nikolaos G Baikoussis; Stavros N Siminelakis; Georgios S Papadopoulos
Journal:  J Cardiothorac Surg       Date:  2010-01-11       Impact factor: 1.637

7.  Modified ultrafiltration reduces postoperative blood loss and transfusions in adult cardiac surgery: a meta-analysis of randomized controlled trials.

Authors:  Zhao Kai Low; Fei Gao; Kenny Yoong Kong Sin; Kok Hooi Yap
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-05-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.